No, I didn't say all biotech analysis in Australia is worthless - I carefully chose the word "most" (Sandstone case in point). I agree with you, there are a small number of well qualified and experienced analysts in Australia and they are the only ones I pay any attention to.
Neuren Media and Analyst Coverage, page-1144
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.66 |
Change
0.060(0.38%) |
Mkt cap ! $1.996B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.61 | $1.596M | 101.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 158 | $15.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 199 | 5 |
View Market Depth
| Last trade - 10.54am 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |